Locations:
Search
Case highlights the utility of a blood substitute product when blood transfusions are not an option
TNF alpha inhibitors: cutaneous side effects and management strategies
Telogen effluvium as a consequence of COVID-19 infection
How to recognize and treat the disease, and field patient questions
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Initially under-recognized, cutaneous manifestations are increasingly reported
Study finds significant histologic differences between TNFi-induced psoriasis and idiopathic psoriasis
What clinicians need to know about cutaneous manifestations of COVID-19
Leveraging the prognostic significance of sentinel lymph node biopsy histologic patterns
Emerging field enables treatment tailored to each patient
Immune checkpoint inhibitor and oncolytic viral immunotherapy produce synergistic effect
Advertisement
Advertisement